UK small-cap RNS · 3 Sep 2026
The key announcements of UK small & mid caps under £2bn on 3 Sep 2026 – situations they move are marked, with the share price since.
Key = all announcements except routine filings (voting rights, buybacks, holdings, director forms), plus director dealings and holdings that are part of a situation. Not investment advice.
| Date | Company | Mcap ↕ | Type | Announcement | |
|---|---|---|---|---|---|
| 3 Sep | Ninety One N91 | £1,875m | Insider conviction | Director/PDMR Shareholding | |
| 3 Sep | Futura Medical FUM | £2.4m | Sale process / strategic review | Retail Offer via the BookBuild Platform
The Company is pleased to announce a retail offer via BookBuild to existing shareholders (the "Retail Offer") of up to 75,000,000 new ordinary shares of 0.2 pence each ("Ordinary Shares") in the capital of the Company (the "Retail Offer Shares") at an issue … |
|
| 3 Sep | Renalytix RENX | £40m | Dilutive fundraise | WRAP Retail Offer for up to £1,000,000
Renalytix is pleased to announce a retail offer via the Winterflood Retail Access Platform ("WRAP") to raise up to £1,000,000 (the "WRAP Retail Offer") through the issue of new ordinary shares of £0.0025 each in the capital of the Company (the "Ordinary … |
|
| 3 Sep | Strategic Minerals SML | £135m | Disposal of a part (break-up) | Leigh Creek – Sale Agreed
Layered consideration provides ongoing exposure to copper upside and supports reinvestment into Redmoor |
|
| 3 Sep | Kazera Global KZG | £17m | Balance-sheet stress / refinancing | Fujax Settlement, Proposed Fundraising & CAW
Fujax Settlement, Proposed Fundraising and Capital Access Window |
|
| 3 Sep | Jadestone Energy JSE | £241m | Stake building towards control | Holding(s) in Company | |
| 3 Sep | Renalytix RENX | £40m | Dilutive fundraise | Result of Fundraise
Renalytix plc (LSE: RENX) (OTCQB: RNLXY), a precision medicine diagnostics company focussed on kidney disease, confirms that, further to the Company's announcement released at 7.01 a.m. on 1 September 2026 (RNS Number: 8254S) (the "Fundraising Announcement"), … |
|
| 3 Sep | Tungsten West TUN | £548m | Project milestones | Financial Results for the Year Ended 31 March 2026
Tungsten West (LON:TUN), the mining company focused on restarting production at the Hemerdon tungsten and tin mine ("Hemerdon" or the "Project") in Devon, UK, is pleased to announce its audited results for the year ended 31 March 2026 and the date of its … |
|
| 3 Sep | Futura Medical FUM | £2.4m | Sale process / strategic review | Fundraise and launch of FSP and M&A process
("Futura" or the "Company" and, together with its subsidiaries, the "Group") |
|
| 3 Sep | EDX Medical Group Plc EDX | £37m | Project milestones | Publication - Annual Report & Financial Statements
Launch of highly accurate early detection testing services for testicular and bowel cancer. |
|
| 3 Sep | Brooks Macdonald Group BRK | £234m | Segment turn | 2026 Full-year results
"Record FUMA, positive net flows and Brooks Financial demonstrating sustained momentum" |
|
| 3 Sep | Hilton Food Group HFG | £645m | Project milestones | Half-year Results
· Good performance from core meat and fresh prepared food, but Foppen weakness. |
|
| 3 Sep | Camellia CAM | £135m | Upgrade / downgrade cycle | Half-year Results
Half year results for the six months ended 30 June 2026 |
|
| 3 Sep | Synectics SNX | £32m | Upgrade / downgrade cycle | £1.4m Award for UK Regional Authority
Ocular selected to provide advanced on-vehicle surveillance technology across 220 new buses |